Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2014 | 11-2013 | 08-2013 | 05-2013 | 02-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -818 | -190 | -654 | -208 | -101 |
| Depreciation Amortization | 30 | 10 | 6 | 1 | 0 |
| Accounts receivable | -144 | -20 | 4 | -3 | N/A |
| Other Working Capital | -95 | -1 | 322 | 117 | 43 |
| Other Operating Activity | 660 | 169 | 217 | 21 | 10 |
| Operating Cash Flow | $-367 | $-32 | $-106 | $-72 | $-48 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | 0 | N/A | N/A | N/A |
| Net Acquisitions | -66 | N/A | -71 | 2 | N/A |
| Investing Cash Flow | $-67 | $0 | $-71 | $2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 884 | 165 | 153 | 53 | 20 |
| Debt Repayment | -414 | -89 | -45 | -25 | -14 |
| Common Stock Issued | 10 | 10 | 106 | 40 | 40 |
| Financing Cash Flow | $480 | $87 | $215 | $68 | $46 |
| Beginning Cash Position | 40 | 40 | 2 | 2 | 2 |
| End Cash Position | 85 | 94 | 40 | 0 | 0 |
| Net Cash Flow | $46 | $55 | $38 | $-2 | $-2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -367 | -32 | -106 | -72 | -48 |
| Capital Expenditure | -1 | 0 | N/A | N/A | N/A |
| Free Cash Flow | -368 | -32 | -106 | -72 | -48 |